Could the 26th finally be the time to announce a combination trial with a check point inhibitor? Looking at the presentations it seems to be a hot topic. A decent amount of financing from the CI partner would also be nice. That may be enough to initiate a nice share price upswing.
Anything you read about Woodford says he prefers a passive relationship. Events just dictated the change.
As far as an associate making a bad division, you are now using an anecdote from AF's writings. The writer was writing about his experience and not talking about the true facts in this case. Funny how he can put the seeds of doubt into weak minds and create havoc.
News 
Market Data 
Discover 
AI
